Year archive

Corona Remedies Limited — 2026 filings

All 101 regulatory filings released by Corona Remedies Limited (CORONA) in 2026, sourced directly from the official regulator.

101 Filings

2026 Period

2026 filings (101)

Filing	Released	Lang
Disclosure under SEBI Takeover Regulations Regulatory Filings	2026-06-03	English
Analysts/Institutional Investor Meet/Con. Call Updates Regulatory Filings	2026-06-03	English
Intimation for Non-Deal Roadshow Regulatory Filings	2026-06-03	English
Analysts/Institutional Investor Meet/Con. Call Updates Regulatory Filings	2026-06-01	English
Intimation for Non-Deal Roadshow Regulatory Filings	2026-06-01	English
Press Release Regulatory Filings	2026-05-28	English
Press Release - Receipt of EU-GMP Certification Regulatory Filings	2026-05-28	English
Disclosure under SEBI Takeover Regulations Regulatory Filings	2026-05-26	English
Disclosure under SEBI Takeover Regulations Regulatory Filings	2026-05-25	English
Disclosure under SEBI Takeover Regulations Regulatory Filings	2026-05-22	English
Updates Notice of Dividend Amount	2026-05-21	English
Communication to Shareholders - Intimation on Tax Deduction on Dividend Notice of Dividend Amount	2026-05-21	English
Analysts/Institutional Investor Meet/Con. Call Updates Investor Presentation	2026-05-19	English
Intimation of participation in Analyst / Investor Conference Regulatory Filings	2026-05-19	English
Analysts/Institutional Investor Meet/Con. Call Updates Call Transcript	2026-05-18	English
Transcript of Earnings call with Analyst/Investor on Financial Results for the fourth quarter and year ended March 31, 2026 Call Transcript	2026-05-18	English
Updates Regulatory Filings	2026-05-12	English
Annual Secretarial Compliance Report for the Financial Year ended March 31, 2026 Regulatory Filings	2026-05-12	English
Annual Secretarial Compliance Report for the Financial Year ended March 31, 2026 Regulatory Filings	2026-05-12	English
Audio Recording of conference call with Analyst / Investor on Financial Results for the fourth quarter and year ended March 31, 2026 Regulatory Filings	2026-05-12	English
Analysts/Institutional Investor Meet/Con. Call Updates Report Publication Announcement	2026-05-12	English
Newspaper Publication of Audited Financial Results for the fourth quarter and year ended on March 31, 2026. Report Publication Announcement	2026-05-12	English
Copy of Newspaper Publication Report Publication Announcement	2026-05-12	English
Analysts/Institutional Investor Meet/Con. Call Updates Investor Presentation	2026-05-11	English
Analyst/Investor Presentation Investor Presentation	2026-05-11	English
Record date for the purpose of Final Dividend for the F.Y. 2025-26 is June 19, 2026 Audit Report / Information FY 2026	2026-05-11	English
Record Date Regulatory Filings	2026-05-11	English
The Board at its meeting held today has recommended Final Dividend (for the F.Y. 2025-26) of Rs. 10/- (100%) per equity share of face value of Rs. 10/- each to the shareholders for their .... Regulatory Filings	2026-05-11	English
Re-appointment of Dr. Kirtikumar Mehta (DIN: 00385658) as the Non Executive Director and Chairman of the Company for the term of five consecutive Financial Years with effective from April 01, 2027 Regulatory Filings	2026-05-11	English
Change in Director(s) Earnings Release FY 2026	2026-05-11	English
Change in Management Interim / Quarterly Report FY 2026	2026-05-11	English
Change in Management Regulatory Filings	2026-05-11	English
Change in Management Regulatory Filings	2026-05-11	English
Change in Auditors Regulatory Filings	2026-05-11	English
Re-appointment of M/s. Manish B. Analkat as the Cost Auditor of the Company for F.Y. 2026-27 Regulatory Filings	2026-05-11	English
Appointment of M/s. Shah & Shah Associates, Chartered Accountants as Internal Auditor of the Company for the F.Y. 2026-27 Regulatory Filings	2026-05-11	English
Re-appointment of M/s. Dhara Patel, peer reviewed Company Secretary Firm as the Secretarial Auditor of the Company for five financial years commencing from F.Y. 2026-27 Audit Report / Information FY 2026	2026-05-11	English
Appointment of M/s. Walker Chandiok & Co LLP, Chartered Accountants as Statutory Auditor of the Company for five consecutive years commencing from conclusion of the 22nd AGM to be held .... Regulatory Filings	2026-05-11	English
Press Release on financial results for Q4FY26 and Year ended March 31, 2026 Earnings Release FY 2026	2026-05-11	English
Press Release Earnings Release FY 2026	2026-05-11	English
Financial Results for the Fourth Quarter and Year ended March 31, 2026 Regulatory Filings	2026-05-11	English
Outcome of Board Meeting Board/Management Information	2026-05-11	English
Dividend Regulatory Filings	2026-05-11	English
Board at its meeting held today, i.e. May 11, 2026 has, inter alia, considered and approved the following: (i) audited Standalone and Consolidated Financial Results along with Audit Reports .... Interim / Quarterly Report FY 2026	2026-05-11	English
Analysts/Institutional Investor Meet/Con. Call Updates Call Transcript	2026-04-30	English
Intimation of Schedule of Analyst / Investor Call Regulatory Filings	2026-04-30	English
Corona Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/05/2026 ,inter alia, to consider and approve a) Audited Financial Results .... Board/Management Information	2026-04-30	English
Certificate under SEBI (Depositories and Participants) Regulations, 2018 Regulatory Filings	2026-04-07	English
Certificate pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the fourth quarter ended March 31, 2026 Regulatory Filings	2026-04-07	English
Press Release Capital/Financing Update	2026-03-30	English
Press Release titled "CORONA Remedies announces strategic acquisition of Wokadine in India" Capital/Financing Update	2026-03-30	English
Trading Window Regulatory Filings	2026-03-30	English
Intimation of Closure of Trading Window Regulatory Filings	2026-03-30	English
Analysts/Institutional Investor Meet/Con. Call Updates Investor Presentation	2026-03-07	English
Intimation of Schedule of Analyst / Investor Meeting Regulatory Filings	2026-03-07	English
Analysts/Institutional Investor Meet/Con. Call Updates Regulatory Filings	2026-02-27	English
Intimation of Schedule of Analyst / Investor Meeting Regulatory Filings	2026-02-27	English
Analysts/Institutional Investor Meet/Con. Call Updates Regulatory Filings	2026-02-17	English
Intimation of participation in Analyst / Investor Conference Investor Presentation	2026-02-17	English
Analysts/Institutional Investor Meet/Con. Call Updates Call Transcript	2026-02-10	English
Transcript of Earnings Conference Call with Analyst / Investor on Financial Results for the third quarter and nine months ended December 31, 2025 Call Transcript	2026-02-10	English
Analysts/Institutional Investor Meet/Con. Call Updates Regulatory Filings	2026-02-03	English
Audio Recording of conference call with Analyst / Investor on financial results for Q3 and Three Months and Nine Months ended December 31, 2025 Regulatory Filings	2026-02-03	English
Copy of Newspaper Publication Report Publication Announcement	2026-02-03	English
Newspaper Publication of Unaudited Financial Results for the third quarter and nine months ended December 31, 2025 Report Publication Announcement	2026-02-03	English
Investor Presentation Investor Presentation	2026-02-02	English
Analyst/Investor Presentation Investor Presentation	2026-02-02	English
Credit Rating Regulatory Filings	2026-02-02	English
Credit Rating Capital/Financing Update	2026-02-02	English
Press Release Earnings Release Q3 2026	2026-02-02	English
Press Release on financial results for Q3FY26 Earnings Release Q3 2026	2026-02-02	English
Financial Results for the Third Quarter and Nine Months ended December 31, 2025 Interim / Quarterly Report 9M 2026	2026-02-02	English
Outcome of Board Meeting Interim / Quarterly Report 9M 2025	2026-02-02	English
Outcome of Board Meeting Interim / Quarterly Report 9M 2025	2026-02-02	English
Updates Regulatory Filings	2026-01-30	English
Intimation of violation under the Company''s Code of Conduct for Regulating, Monitoring and Reporting of Insider Trading in securities and the SEBI (Prohibition of Insider Trading) Regulations, 2015 Regulatory Filings	2026-01-30	English
Analysts/Institutional Investor Meet/Con. Call Updates Regulatory Filings	2026-01-28	English
Intimation of Schedule of Analyst / Investor Call Regulatory Filings	2026-01-28	English
Corona Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/02/2026 ,inter alia, to consider and approve Board Meeting intimation for .... Regulatory Filings	2026-01-27	English
Press Release Regulatory Filings	2026-01-21	English
Press Release Regulatory Filings	2026-01-21	English
General Updates Regulatory Filings	2026-01-19	English
Intimation under Regulation 30-GMP Certificate of Compliance from Eurasian Economic Union Regulatory Filings	2026-01-19	English
Analysts/Institutional Investor Meet/Con. Call Updates Call Transcript	2026-01-12	English
Transcript of Earnings Conference Call with Analyst / Investor on Financial Results for the second quarter and half year ended September 30, 2025 Call Transcript	2026-01-12	English
Certificate under SEBI (Depositories and Participants) Regulations, 2018 Regulatory Filings	2026-01-06	English
Certificate pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the third quarter ended December 31, 2025 Regulatory Filings	2026-01-06	English
Analysts/Institutional Investor Meet/Con. Call Updates Call Transcript	2026-01-05	English
Audio Recording of conference call with Analyst / Investor on financial results for Q2 and half year ended September 30, 2025 Regulatory Filings	2026-01-05	English
Investor Presentation Investor Presentation	2026-01-03	English
Analyst/Investor Presentation Investor Presentation	2026-01-03	English
Copy of Newspaper Publication Interim / Quarterly Report H1 2025	2026-01-03	English
Newspaper Publication of Unaudited Financial Results for the second quarter and half year ended September 30, 2025 Interim / Quarterly Report H1 2025	2026-01-03	English
Outcome of Board Meeting Interim / Quarterly Report H1 2025	2026-01-02	English
Press Release Earnings Release Q2 2026	2026-01-02	English
Press Release on financial results for Q2FY26 Earnings Release Q2 2026	2026-01-02	English
Financial Results for the second quarter and half year ended September 30, 2025 Interim / Quarterly Report H1 2025	2026-01-02	English
Outcome of Board Meeting Interim / Quarterly Report H1 2025	2026-01-02	English
Outcome of Board Meeting Interim / Quarterly Report H1 2025	2026-01-02	English
Updates Regulatory Filings	2026-01-01	English
Intimation for updation of CIN of the Company Regulatory Filings	2026-01-01	English